Page last updated: 2024-09-04

docetaxel anhydrous and Conus Medullaris Syndrome

docetaxel anhydrous has been researched along with Conus Medullaris Syndrome in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Anton, A; Azad, A; Gibbs, P; Goh, J; Gunjur, A; Kwan, EM; Parente, P; Parnis, F; Pezaro, C; Semira, MC; Shapiro, J; Spain, L; Torres, J; Tran, B; Weickhardt, A; Wong, S	1
Abdeen, G; Kamona, A; Massarweh, S; Sapp, C; Wilson, B	1
Bloomfield, D; James, ND; Luscombe, C	1

Reviews

1 review(s) available for docetaxel anhydrous and Conus Medullaris Syndrome

Article	Year
The changing pattern of management for hormone-refractory, metastatic prostate cancer. Prostate cancer and prostatic diseases, 2006, Volume: 9, Issue:3 Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Diphosphonates; Docetaxel; Drug Resistance, Neoplasm; Humans; Male; Mitoxantrone; Neoplasm Metastasis; Palliative Care; Prednisolone; Prostatic Neoplasms; Spinal Cord Compression; Taxoids; Urologic Diseases	2006

Article

Year

The changing pattern of management for hormone-refractory, metastatic prostate cancer.

Prostate cancer and prostatic diseases, 2006, Volume: 9, Issue:3

Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Diphosphonates; Docetaxel; Drug Resistance, Neoplasm; Humans; Male; Mitoxantrone; Neoplasm Metastasis; Palliative Care; Prednisolone; Prostatic Neoplasms; Spinal Cord Compression; Taxoids; Urologic Diseases

2006

Other Studies

2 other study(ies) available for docetaxel anhydrous and Conus Medullaris Syndrome

Article	Year
Real-world incidence of symptomatic skeletal events and bone-modifying agent use in castration-resistant prostate cancer - an Australian multi-centre observational study. European journal of cancer (Oxford, England : 1990), 2021, Volume: 157 Topics: Adult; Aged; Aged, 80 and over; Androstenes; Antineoplastic Agents; Australia; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Docetaxel; Humans; Incidence; Male; Middle Aged; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Spinal Cord Compression; Treatment Outcome; Zoledronic Acid	2021
Resolution of extensive leptomeningeal metastasis and clinical spinal cord compression from breast cancer using weekly docetaxel chemotherapy. Breast cancer research and treatment, 2012, Volume: 131, Issue:1 Topics: Antineoplastic Agents; Breast Neoplasms; Central Nervous System; Chemotherapy, Adjuvant; Docetaxel; Female; Humans; Meningeal Neoplasms; Middle Aged; Spinal Cord Compression; Taxoids	2012

Article

Year

Real-world incidence of symptomatic skeletal events and bone-modifying agent use in castration-resistant prostate cancer - an Australian multi-centre observational study.

European journal of cancer (Oxford, England : 1990), 2021, Volume: 157

Topics: Adult; Aged; Aged, 80 and over; Androstenes; Antineoplastic Agents; Australia; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Docetaxel; Humans; Incidence; Male; Middle Aged; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Spinal Cord Compression; Treatment Outcome; Zoledronic Acid

2021

Resolution of extensive leptomeningeal metastasis and clinical spinal cord compression from breast cancer using weekly docetaxel chemotherapy.

Breast cancer research and treatment, 2012, Volume: 131, Issue:1

Topics: Antineoplastic Agents; Breast Neoplasms; Central Nervous System; Chemotherapy, Adjuvant; Docetaxel; Female; Humans; Meningeal Neoplasms; Middle Aged; Spinal Cord Compression; Taxoids

2012